Literature DB >> 9032380

The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad.

J P Engel1, T C Madigan, G M Peterson.   

Abstract

The mouse hind footpad inoculation model has served as a standard laboratory system for the study of the neuropathogenesis of herpes simplex virus type 1 (HSV-1) infection. The temporal and spatial distribution of viral antigen, known as the transneuronal spread phenotype, has not previously been described; nor is it understood why mice develop paralysis in an infection that involves sensory nerves. The HSV-as-transneuronal-tracer experimental paradigm was used to define the transneuronal spread of HSV-1 in this model. A new decalcification technique and standard immunocytochemical staining of HSV-1 antigens enabled a detailed analysis of the time-space distribution of HSV-1 in the intact spinal column. Mice were examined on days 3, 4, 5, and 6 postinoculation (p.i.) of a lethal dose of wild-type HSV-1 strain 17 syn+. Viral antigen was traced retrograde into first-order neurons in dorsal root ganglia on day 3 p.i., to the dorsal spinal roots on days 4 and 5 p.i., and to second- and third-order neurons within sensory regions of the spinal cord on days 5 and 6 p.i. HSV-1 antigen distribution was localized to the somatotopic representation of the footpad dermatome within the dorsal root ganglia and spinal cord. Antigen was found in the spinal cord gray and white matter sensory neuronal circuits of nociception (the spinothalamic tract) and proprioception (the dorsal spinocerebellar tract and gracile fasciculus). Within the brain stems and brains of three paralyzed animals examined late in infection (days 5 and 6 p.i.), HSV antigen was restricted to the nucleus subcoeruleus region bilaterally. Since motor neurons were not directly involved, we postulate that hindlimb paralysis may have resulted from intense involvement of the posterior column (gracile fasciculus) in the thoracolumbar spinal cord, a region known to contain the corticospinal tract in rodents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032380      PMCID: PMC191353     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Comparative neurovirulence and latency of HSV1 and HSV2 following footpad inoculation in mice.

Authors:  R R McKendall
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

2.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

3.  Morphological studies of the neural spread of herpes simplex virus to the central nervous system.

Authors:  K Kristensson
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

4.  The pathogenesis of pseudorabies in mice following peripheral inoculation.

Authors:  H J Field; T J Hill
Journal:  J Gen Virol       Date:  1974-05       Impact factor: 3.891

5.  The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord.

Authors:  C Molander; Q Xu; G Grant
Journal:  J Comp Neurol       Date:  1984-11-20       Impact factor: 3.215

6.  Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei.

Authors:  K Kristensson; L Nennesmo; L Persson; E Lycke
Journal:  J Neurol Sci       Date:  1982-04       Impact factor: 3.181

7.  Ultrastructural and immunoperoxidase study of striatonigral neurons by means of retrograde axonal transport of herpes simplex virus.

Authors:  I J Bak; C H Markham; M L Cook; J G Stevens
Journal:  Brain Res       Date:  1978-03-24       Impact factor: 3.252

8.  Intraaxonal transport of Herpes simplex virus in the rat central nervous system.

Authors:  I J Bak; C H Markham; M L Cook; J G Stevens
Journal:  Brain Res       Date:  1977-11-18       Impact factor: 3.252

9.  Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation.

Authors:  K Kristensson; A Vahlne; L A Persson; E Lycke
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

View more
  6 in total

1.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

2.  Virulent Pseudorabies Virus Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice.

Authors:  K Laval; J B Vernejoul; J Van Cleemput; O O Koyuncu; L W Enquist
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

3.  Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis.

Authors:  Melanie A Samuel; Hong Wang; Venkatraman Siddharthan; John D Morrey; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

4.  T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response.

Authors:  Kaiting Yang; Yong Liang; Zhichen Sun; Diyuan Xue; Hairong Xu; Mingzhao Zhu; Yang-Xin Fu; Hua Peng
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

5.  Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Authors:  Yong Liang; Kaiting Yang; Jingya Guo; Joanna Wroblewska; Yang-Xin Fu; Hua Peng
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

6.  Role of Caspases and Gasdermin A during HSV-1 Infection in Mice.

Authors:  Lupeng Li; Stephen B Kovacs; Ine Jørgensen; Heather N Larson; Helen M Lazear; Edward A Miao
Journal:  Viruses       Date:  2022-09-13       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.